Events
-
-
Diabetes SIG Meeting
The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org.
-
PES Leader Orientation
For New and Returning SIG and Committee Leaders! Reach out to info@pedsendo.org for more information or the zoom link. The session will be recorded and made available to leaders following.
-
-
PES Turner Syndrome SIG
For more information on the TS SIG, click here. To join a SIG, click here.
-
PES Public Policy Committee Meeting
For more information on the Public Policy Committee, click here. To join a committee, click here.
-
Industry Sponsored Symposium: Navigating CAH: An Interactive Case Study Approach for Pediatric Specialists
September 10, 2025 | 12:00 – 1:00 PM ET Sponsored by: Medscape Education. Supported by an independent educational grant from Neurocrine Biosciences, Inc. PROGRAM DESCRIPTION Congenital adrenal hyperplasia (CAH) presents complex, lifelong challenges that impact patients' quality of life—from growth suppression in children to long-term metabolic and psychological effects. This symposium offers clinicians a unique opportunity to…
-
Ethics and DSD Journal Club: What’s in a name?
Brief Description You are invited to join an interactive discussion of a recent commentary published in Nature Reviews Urology titled "Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD" (https://doi.org/10.1038/s41585-025-01035-5). Part of the discussion will include an opportunity to hear from and dialogue with some of the authors. Learning Objectives Understand the…
-
Diabetes SIG Meeting
The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. If you’re interested in joining the Diabetes SIG, click here. If you need the meeting link, please reach out to info@pedsendo.org.
-
-
Industry Sponsored Symposium: A New Treatment Era for Congenital Adrenal Hyperplasia: Androgen Management and Glucocorticoid Dose Reduction in Clinical Practice
Industry Sponsored Symposium: A New Treatment Era for Congenital Adrenal Hyperplasia: Androgen Management and Glucocorticoid Dose Reduction in Clinical Practice October 1, 2025 I 12:00 – 1:00 PM MT (2pET) Sponsored by: Neurocrine Biosciences PROGRAM DESCRIPTION This interactive, case-based presentation will provide an in-depth look at clinical data for a newly approved, non-glucocorticoid treatment for classic congenital adrenal…
-
Industry Sponsored Symposium: Managing Achondroplasia Together: Physician and Caregiver Perspectives
Industry Sponsored Symposium: Managing Achondroplasia Together: Physician and Caregiver Perspectives Sponsored by BioMarin Pharmaceutical Inc. October 7th 7:00-8:00 pm ET Learn about the underlying cause of inhibited bone growth in achondroplasia and explore management options with a clinical expert. Hear from a caregiver as they share their experiences and perspectives navigating achondroplasia. Speaker …
-
PES Obesity SIG Meeting
For more information on the Obesity SIG, click here. To join a SIG, click here.
-
PES Podcast Club: The Immortal Life of Henrietta Lacks
Podcast Club: The Immortal Life of Henrietta Lacks Tuesday, October 14, 2025, 8:00pm Eastern time We’re excited to announce that we will be discussing The Immortal Life of Henrietta Lacks and its related podcast. The Immortal Life of Henrietta Lacks Join us for robust discussion: https://zoom.us/meeting/register/fyPzlN_JSh-h1ydgUzTuaw The Immortal Life of Henrietta Lacks How one woman,…
-
Quarterly Education Committee Webinar: Dyslipidemia in Diabetes and Beyond
Date: Monday, October 20, 2025 / 4:00 pm – 5:00 pm EST Title: Dyslipidemia in Diabetes and Beyond Learning objectives: Analyze the pathophysiology between dyslipidemia and diabetes Assess current evidence-based guidelines and management strategies for managing dyslipidemia in pediatric diabetes and other high risk pediatric populations Develop tailored interventions for those who do not respond to…